Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

We investigated the effects of the cholesteryl ester (CE) transfer protein inhibitor anacetrapib (ANA) on plasma lipids, lipoprotein subfraction concentrations, and lipoprotein composition in 30 healthy individuals. Participants (n = 30) were randomized to ANA 20 mg/day, 150 mg/day, or placebo for 2...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Krauss, Ronald M., Wojnooski, Kathleen, Orr, Joseph, Geaney, J. Casey, Pinto, Cathy Anne, Liu, Yang, Wagner, John A., Luk, Julie Mabalot, Johnson-Levonas, Amy O., Anderson, Matt S., Dansky, Hayes M.
Формат: Artigo
Язык:Inglês
Опубликовано: The American Society for Biochemistry and Molecular Biology 2012
Предметы:
Patient-Oriented and Epidemiological Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276477/
https://ncbi.nlm.nih.gov/pubmed/22180633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M018010
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы